Diacylglycerol kinase modulating compounds

The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

Saved in:
Bibliographic Details
Main Authors Graupe, Michael, Kobayashi, Tetsuya, Guerrero, Juan A, Holmbo, Stephen D, Xu, Jie, Yeung, Suet C, Weaver, Heath A, Jacobsen, Jesse M, Patel, Leena B
Format Patent
LanguageEnglish
Published 19.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
Bibliography:Application Number: US202217845469